Possible side effects include somnolence and insomnia, therefore it is kink of hard to suggest when to take it.
In clinical trials in patients with major depressive disorder, the incidence of EPS-related adverse reactions, excluding akathisia, was 6% (3% in placebo patients). Akathisia occurred in 9% of patients (2% in placebo patients). The incidence of akathisia was dose-related. In clinical trials in patients with schizophrenia, the incidence of EPS-related adverse reactions, excluding akathisia, was 5% (4% in placebo patients). Akathisia occurred in 6% of patients (5% in placebo patients).[Ref]
Common (1% to 10%): Akathisia, headache, somnolence, tremor, dizziness, sedation, extrapyramidal-related events (excluding akathisia)[Ref]
Common (1% to 10%): Anxiety, restlessness, abnormal dreams, insomnia[Ref]
The incidence of restlessness was dose-related in patients with major depressive disorder receiving this drug in combination with an antidepressant.[Ref]
- Brexpiprazole Information for Consumers
- Brexpiprazole Information for Healthcare Professionals (includes dosage details)
- Side Effects of Brexpiprazole (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 27 Mar 2015 • 5 answers
Posted 10 Mar 2016 • 1 answerFAQ by Drugs.com
Posted 8 May 2016 • 1 answer
Posted 24 Nov 2016 • 1 answer
Major Depressive Disorder - Hi - I have been suffering from treatment resistant major depression for
Posted 5 Mar 2017 • 1 answer